Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma

Histology and Histopathology

Volumn 26, Issue 7, 2011, Pages 893-904

  Sullivan, Jennifer ^a   Blair, Laurel ^a   Alnajar, Amer ^a   Aziz, Tamer ^a   Chipitsynas, Glina ^a   Gong, Qiaoke ^a   Yeo, Charles J ^a   Arafat, Hwyda A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Igarette smoke; Nicotine receptor; Osteopontin; Pancreatic cancer

Indexed keywords

BUNGAROTOXIN RECEPTOR; ISOPROTEIN; MESSENGER RNA; NICOTINE; NICOTINIC RECEPTOR; OSTEOPONTIN; PRIMER DNA; RNA;

ARTICLE; CELL MOTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SMOKING; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NICOTINE; OSTEOPONTIN; PANCREATIC NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, NICOTINIC; RISK FACTORS; RNA, MESSENGER; RNA, NEOPLASM; SMOKING;

EID: 79960691745     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arias H.R., Richards V.E., Ng D., Ghafoori M.E., Le V. and Mousa S.A. 2009). Role of non-neuronal nicotinic acetylcholine receptors in ngiogenesis. Int. J. Biochem. Cell Biol. 41, 1441-1451.
2. Brown L.F., Papadopoulos-Sergiou A., Berse B., Manseau E.J., ognazzi K., Perruzzi C.A., Dvorak H.F. and Senger D.R. (1994). Oteopontin expression and distribution in human carcinomas. Am. J. Pathol. 145, 610-623.
3. Catassi A., Servent D., Paleari L., Cesario A. and Russo P. (2008). Multiple roles of nicotine on cell proliferation and inhibition of poptosis: implications on lung carcinogenesis. Mutat. Res. 659, 21-231.
4. Chakraborty G., Jain S. and Kundu G.C. (2008). Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth nd angiogenesis via autocrine and paracrine mechanisms. Cancer es. 68, 152-161.
5. Chipitsyna G., Gong Q., Anandanadesan R., Alnajar A., Batra S.K., Wittel U.A., Cullen D.M., Akhter M.P., Denhardt D.T., Yeo C.J. and rafat H.A. (2009). Induction of osteopontin expression by nicotine nd cigarette smoke in the pancreas and pancreatic ductal denocarcinoma cells. Int. J. Cancer 125, 276-285.
6. Chowdhury P., Rayford P.L. and Chang LW. (1992). Inductions of ancreatic acinar cell pathology via inhalation of nicotine. Proc. Soc. xp. Biol. Med. 20, 159-164.
7. Denhardt D.T., Noda M., O'Regan A.W., Palvin D. and Berman J.S. 2001). Osteopontin as a means to cope with environmental insults: egulation of inflammation, tissue remodeling, and cell survival. J. lin. Invest. 107, 1055-1061.
8. Farrow D.C. and Davis S. (1990). Risk of pancreatic cancer in relation to medical history and use of tobacco, alcohol and coffee. Int. J. Cancer 45, 816-820.
9. He B., Mirza M. and Weber G.F. (2006). An osteopontin splice variant nduces anchorage independence in human breast cancer cells.Oncogene 25, 2192-2202.
10. Jemal A., Siegel R., Xu J. and Ward E. (2010). Cancer statistics, 2010. A. Cancer J. Clin. 60, 277-300.
11. Kasugai S., Zhang Q., Overall C.M., Wrana J.L., Butler W.T. and Sodek N. (1991). Differential regulation of the 55 and 44 kDa forms of ecreted phosphoprotein 1 (SPP-1, osteopontin) in normal and ransformed rat bone cells by osteotropic hormones, growth factors nd a tumor promoter. Bone Miner. 13, 235-250.
12. Khan S.A., Cook A.C., Kappil M., Günthert U., Chambers A.F., Tuck B. and Denhardt D.T. (2005). Enhanced cell surface CD44 variant v6, v9) expression by osteopontin in breast cancer epithelial cells acilitates tumor cell migration: novel post-transcriptional, posttranslational egulation. Clin. Exp. Metastasis 22, 663-673.
13. Kolb A., Kleeff J., Guweidhi A., Esposito I., Giese N.A., Adwan H., Giese T., Büchler M.W., Berger M.R. and Friess H. (2005). Osteopontin nfluences the invasiveness of pancreatic cancer cells and is ncreased in neoplastic and inflammatory conditions. Cancer Biol. her. 4, 740-746.
14. Kon S., Maeda M., Segawa T., Horikoshi Y., Tsukagoshi H., Rashid M., Morimoto J., Inobe M., Shijubo N., Chambers A.F. and Uede T. (2000). Antibodies to different peptides in osteopontin reveal omplexities in the various secreted forms. J. Cell Biochem. 77, 487-498.
15. Koopmann J., Rosenzweig C.N., Zhang Z., Canto M.I., Brown D.A., unter M., Yeo C., Chan D.W., Breit S.N. and Goggins M. (2006). Serum markers in patients with resectable pancreatic denocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. lin. Cancer Res. 12, 442-446.
16. Lowenfels A.B. and Maisonneuve P. (2006). Epidemiology and risk actors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol. 20, 197-209.
17. Lin Y.H. and Yang-Yen H.F. (2001). The osteopontin-CD44 survival ignal involves activation of the phosphatidylinositol 3- kinase/Akt ignaling pathway. J. Biol. Chem. 276, 46024-46030.
18. Mi Z., Guo H., Wai P.Y., Gao C. and Kuo P.C. (2006). Integrin linked inase regulates osteopontin-dependent MMP-2 and Upa xpression to convey metastatic function in murine mammary pithelial cancer cells. Carcinogenesis 27, 1134-1145.
19. Mirza M., Shaughnessy E., Hurley J.K., Vanpatten K.A., Pestano G.A., He B. and Weber G.F. (2008). Osteopontin-c is a selective marker of reast cancer. Int. J. Cancer 122, 889-897.
20. Rittling S.R. and Chambers A.F. (2004). Role of osteopontin in tumour rogression. Br. J. Cancer 90, 1877-1881.
21. Schuller H.M. (2007). Nitrosamines as nicotinic receptor ligands. Life sci. 80, 2274-2280.
22. Shevde L.A., Samant R.S., Paik J.C., Metge B.J., Chambers A.F., asey G., Frost A.R. and Welch D.R. (2006). Osteopontin nockdown suppresses tumorigenicity of human metastatic breast arcinoma, MDA-MB-435. Clin. Exp. Metastasis 23, 123-133.
23. Silverman D.T., Dunn J.A., Hoover R.N., Schiffman M., Lillemoe K.D., choenberg J.B., Brown L.M., Greenberg R.S., Hayes R.B. and wanson G.M. (1994). Cigarette smoking and pancreas cancer: a ase control study based on direct interviews. J. Natl. Cancer Inst. 6, 1510-1516.
24. Takafuji V., Forgues M., Unsworth E., Goldsmith P. and Wang X.W. 2007). An osteopontin fragment is essential for tumor cell invasion n hepatocellular carcinoma. Oncogene 26, 6361-6371.
25. Tuck A.B., Hota C., Wilson S.M. and Chambers A.F. (2003). Osteopontin-induced migration of human mammary epithelial cells nvolves activation of EGF receptor and multiple signal transduction athways. Oncogene 22, 1198-1205.
26. Wai P.Y. and Kuo P.C. (2008). Osteopontin: regulation in tumor etastasis. Cancer Metastasis Rev. 27, 103-118.
27. Wai P.Y., Guo L., Gao C., Mi Z., Guo H. and Kuo P.C. (2006). Osteopontin inhibits macrophage nitric oxide synthesis to enhance umor proliferation. Surgery 40, 132-140.
28. Wang X.L. and Wang J. (2005). Smoking-gene interaction and disease evelopment: relevance to pancreatic cancer and atherosclerosis. World J. Surg. 29, 344-353.
29. Warshaw A.L. and Ferandez-Del Castillo C. (1992). Pancreatic arcinoma. N. Engl. J. Med. 326, 455-465.
30. Weber G.F. and Ashkar S. (2000). Stress response genes - the genes hat make cancer metastasize. J. Mol. Med. 78, 404-408.
31. Zhu B.Q., Heeschen C., Sievers R.E., Karliner J.S., Parmley W.W., lantz S.A. and Cooke J.P. (2003). Second hand smoker stimulates umor angiogenesis and growth. Cancer Cell 4, 191-196.